December 2009- Volume 5, Issue 12

December 2009

In this Issue

Research & Development

Unbreak that heart

Unbreak that heart

Gladstone and Stanford collaborate on developing IPS cells to repair damaged heart muscle

Partnering up for mutual gain

Partnering up for mutual gain

Quintiles forms strategic alliances with AstraZeneca and Eisai in back-to-back deals, following up on an earlier Allergan deal

Venturing into vaccines

Venturing into vaccines

TapImmune taps Crucell’s cell line for vaccine development

SurModics and NuPathe partner on long-acting Parkinson’s treatment

SurModics and NuPathe partner on long-acting Parkinson’s treatment

SurModics Inc., a provider of drug delivery and surface modification technologies to the healthcare industry, and NuPathe Inc., a neuroscience-focused specialty pharmaceutical company, announced in November that they signed a license agreement for NP201, the first long-acting treatment available in broadly acceptable dose form that maintains the potential to provide sustained relief from Parkinson’s disease without motor response complications.

Tempting fate

Tempting fate

Fate Therapeutics unveils creation of small-molecule program for commercial-scale reprogramming

Shining a light on cancer

Shining a light on cancer

Two years into oncology research agreement, GE and Lilly develop technology to visualize and map complex biomarker networks

Genomics & Proteomics

Partners in proteomics

Partners in proteomics

Belgian firm Eurogentec expands its reach into the proteomics space with AnaSpec acquisition

Show me the way

Show me the way

Dutch firm InteRNA Technologies and Dana-Farber Cancer Institute collaborate on the role of microRNAs in cancer pathways

The ‘Scout’ rounds up some business

The ‘Scout’ rounds up some business

Kinaxo secures deals with Roche, Bayer Vital and Janssen in October around its novel phosphoproteomics platform, PhosphoScout

1000 x 1000 human genomes in five years

1000 x 1000 human genomes in five years

Huntington’s disease project to sequence an unprecedented 100 human genomes in first six months

SuperGen CLIMBs on board with GSK

SuperGen CLIMBs on board with GSK

Companies will collaborate on development of novel epigenetic therapeutics

Global News

Cross-pond collaboration

Cross-pond collaboration

U.K., U.S. biotech trade groups join forces to promote industry

Three’s a crowd

Three’s a crowd

Lundbeck acquires French CMO and principal supplier Elaiapharm

Say ‘yes’ to nosocomial

Say ‘yes’ to nosocomial

MorphoSys and Daiichi Sankyo forge alliance to develop novel antibody therapies against hospital-acquired infections

Takeda, Amylin ink weighty deal

Takeda, Amylin ink weighty deal

Companies in $1 billion-plus agreement to co-develop and commercialize compounds for obesity

Informatics

Perfect union

Perfect union

Thermo Fisher Watson LIMS and Symyx Notebook integrated to reduce bioanalytical workflow error and improve efficiency and reporting

Sifting through genes

Sifting through genes

Eurofins MWG Operon selects Geospiza's GeneSifter to automate DNA sequencing data analysis

In pursuit of the paperless clinical trial

In pursuit of the paperless clinical trial

IntraLinks announces Adobe-based paperless solution for clinical trial process

Peta-flogging HIV

Peta-flogging HIV

Blazingly fast IBM-designed supercomputer is helping Los Alamos researchers focus on promising HIV vaccine targets

New Products

Streamlined integration of pipetting with heating and shaking

Streamlined integration of pipetting with heating and shaking

Hamilton Robotics has introduced the MICROLAB NIMBUS Heater/Shaker Package, an integrated system that incorporates high-speed automated pipetting with orbital plate shaking and heating.

Sample preparation reagent provides reverse transcription-ready RNA in five minutes

Sample preparation reagent provides reverse transcription-ready RNA in five minutes

Bio-Rad Laboratories Inc. has launched the iScript RT-qPCR Sample Preparation Reagent for rapid isolation of total RNA and enabling reverse transcription and real-time PCR to be performed directly from cell lysates.

Automation & Instrumentation

Handy for growth

Handy for growth

BD plans to acquire HandyLab to boost its molecular diagnostics offering

Nanoscale technology deal a tight fit

Nanoscale technology deal a tight fit

Agilent Technologies and Stanford University ink nanoscale collaboration deal

Epic developments are in the works

Epic developments are in the works

Corning and PerkinElmer collaborate on development of label-free detection technologies

Shedding labels

Shedding labels

Caliper Life Sciences, SRU Biosystems to offer label-free services for cell-based and biochemical assays

Label-free: The way to be?

Label-free: The way to be?

SBS hosts symposium on label-free technologies

Commentary

Drug discovery paradigm could shift with cancer center involvement

Drug discovery paradigm could shift with cancer center involvement

Collaborations between data and computation-driven systems biology companies and forward-thinking oncology clinics are poised to change the face of cancer drug development and cancer itself.

Patent News

Supreme Court ponders what is patentable in Bilski case

Supreme Court ponders what is patentable in Bilski case

Is Bilski important? Some estimates say as many as 200,000 patents could be invalidated if Bilski is held to strictly apply to all method patents. For the biotech industry, the decision has significant ramifications for the patentability of many inventions, particularly diagnostics and personalized medicine.

Editor's Focus

‘Twas the year of the M&A boom …

‘Twas the year of the M&A boom …

‘Twas the end of 2009, and in the ddn newsroom, the editors and writers gathered to reflect on Big Pharma’s M&A boom.
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022